An international team, led by researchers from Australia, have developed a system using nanotechnology that could allow people with diabetes to take oral insulin in the future. The researchers say the new insulin could be eaten by taking a tablet or even embedded within a piece of chocolate.
The new nano carrier, tested in mice, rats and baboon animal models, could help people with diabetes avoid side-effects linked to insulin injections such as hypoglycemia (a low blood sugar event, when too much insulin has been injected).
These animal studies have shown that the greatest strength of the nano-scale material is that it can react to the body’s blood sugar levels. The coating dissolves and releases the insulin when there is a high concentration of blood sugar and importantly does not release the insulin in low blood sugar environments.
The new oral insulin uses a type of nano-scale material that is 1/10,000th the width of a human hair. The material acts similarly to acid resistant coating on tablets, which protects it from being destroyed by stomach acid. But this new coating instead surrounds individual insulin molecules and becomes a “nano carrier”—acting like a courier to ferry insulin molecules in the body to the places it needs to act.
The findings are published in Nature Nanotechnology.
It is estimated 422 million people worldwide have diabetes, and approximately 75 million of these inject themselves with insulin daily. Around 1.5 million deaths are directly attributed to diabetes each year. In 2021, it was estimated more than 1.3 million Australians were living with diabetes.
Lead author Dr. Nicholas Hunt from the University of Sydney’s School of Medical Sciences in the Faculty of Medicine and Health, says the development of a safe and effective oral insulin has been a challenge since insulin was discovered over a century ago.
“A huge challenge that was facing oral insulin development is the low percentage of insulin that reaches the blood stream when given orally or with injections of insulin,” says Dr. Hunt, who is also a member of the University of Sydney Nano Institute and Charles Perkins Center.
“To address this, we developed a nano carrier that drastically increases the absorbance of our nano insulin in the gut when tested in human intestinal tissue.”
Preclinical testing in animal models found that, following ingestion, the nano insulin was able to control blood glucose levels without hypoglycemia or weight gain. There was also no toxicity.
“Our oral insulin has the added benefit of greatly reducing the risk of hypoglycemic episodes. For the first time we have developed an oral insulin that overcomes this major hurdle,” said Dr. Hunt.
Human trials are expected to start in 2025 led by the spin out company Endo Axiom Pty Ltd.
Endo Axiom Pty Ltd was founded by Professor Victoria Cogger, Professor David Le Couteur AO and Dr. Nicholas Hunt, after 20 years of research.
Dr. Hunt and his team were driven to develop oral insulin technology given it could help lighten the economic, health and well-being burden related to diabetes management for patients.
“We wanted to devote our time to develop successful oral insulin technology because we believe it will help people with diabetes have more control over their condition.”
Senior author Professor Victoria Cogger, director of The ANZAC Research Institute, said the development of oral insulin is the culmination of many years of scientific endeavor and collaboration.
“It’s wonderful to see our work published, supported by Endo Axiom and reaching clinical trials?—to be able to lead a change in the way we treat a disease that impacts so many people,” she said.
Professor Cogger said when her work first began on creating an oral insulin it was a purely scientific question, but then a family member became impacted by type 1 diabetes.
“Life is strange and along the way my family was impacted by a type 1 diabetes diagnosis, and I really started to understand the reality of what life is like on injectable insulin therapy.
“Having that lived experience has driven the project in many ways and created an impetus to improve life for all people living with diabetes. My hope is we can reduce the multi-faceted burden of diabetes through easily accessible oral insulin.”
More information: Nicholas J. Hunt et al, Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia, Nature Nanotechnology (2024). DOI: 10.1038/s41565-023-01565-2
Journal information: Nature Nanotechnology
Provided by University of Sydney
News
Japanese dentists test drug to help people with missing teeth regrow new ones
Japanese dentists are testing a groundbreaking drug that could enable people with missing teeth to grow new ones, reducing the need for dentures and implants, AFP recently reported. Katsu Takahashi, head of oral surgery at [...]
An AI system has reached human level on a test for ‘general intelligence’
A new artificial intelligence (AI) model has just achieved human-level results on a test designed to measure "general intelligence." On December 20, OpenAI's o3 system scored 85% on the ARC-AGI benchmark, well above the previous AI best [...]
According to Researchers, Your Breathing Patterns Could Hold the Key to Better Memory
Breathing synchronizes brain waves that support memory consolidation. A new study from Northwestern Medicine reports that, much like a conductor harmonizes various instruments in an orchestra to create a symphony, breathing synchronizes hippocampal brain waves to [...]
The Hidden Culprit Behind Alzheimer’s Revealed: Microglia Under the Microscope
Researchers at the CUNY Graduate Center have made a groundbreaking discovery in Alzheimer’s disease research, identifying a critical link between cellular stress in the brain and disease progression. Their study focuses on microglia, the brain’s immune [...]
“Mirror Bacteria” Warning: A New Kind of Life Could Pose a Global Threat
Mirror life, a concept involving synthetic organisms with reversed molecular structures, carries significant risks despite its potential for medical advancements. Experts warn that mirror bacteria could escape natural biological controls, potentially evolving to exploit [...]
Lingering Viral Fragments: The Hidden Cause of Long COVID
Long COVID, affecting 5-10% of COVID-19 patients, might be caused by the enduring presence of the virus in the body. Research suggests that viral fragments, possibly live, linger and lead to symptoms. Addressing this involves antiviral treatments, enhanced [...]
Hidden Scars: How COVID Lockdowns Altered Teen Brains Forever
Research from the University of Washington revealed that COVID-19 lockdowns led to accelerated cortical thinning in adolescents, impacting brain development significantly. This effect was more pronounced in females than males, raising concerns about long-term brain health. The study [...]
Simple Blood Test To Detect Dementia Before Symptoms Appear
UCLA researchers have identified placental growth factor (PlGF) as a potential blood biomarker for early detection of cognitive impairment and dementia. High PlGF levels correlate with increased vascular permeability, suggesting its role in the development [...]
Investing Goldman Sachs asks ‘Is curing patients a sustainable business model?’
Goldman Sachs analysts attempted to address a touchy subject for biotech companies, especially those involved in the pioneering “gene therapy” treatment: cures could be bad for business in the long run. “Is curing patients [...]
The risks of reversed chirality: Study highlights dangers of mirror organisms
A groundbreaking study evaluates the feasibility, risks, and ethical considerations of creating mirror bacteria with reversed chirality, highlighting potential threats to health and ecosystems. In a recent study published in Science, a team of researchers [...]
Alarming Mutation in H5N1 Virus Raises Pandemic Red Flags
NIH-funded study concludes that the risk of human infection remains low A recent study published in Science and funded by the National Institutes of Health (NIH) has found that a single alteration in a protein on the surface [...]
Scientists Discover Genetic Changes Linked to Autism, Schizophrenia
The Tbx1 gene influences brain volume and social behavior in autism and schizophrenia, with its deficiency linked to amygdala shrinkage and impaired social incentive evaluation. A study published in Molecular Psychiatry has linked changes in brain [...]
How much permafrost will melt this century, and where will its carbon go?
Among the many things global warming will be melting this century—sea ice, land glaciers and tourist businesses in seaside towns across the world—is permafrost. Lying underneath 15% of the northern hemisphere, permafrost consists of [...]
A Physics Discovery So Strange It’s Changing Quantum Theory
MIT physicists surprised to discover electrons in pentalayer graphene can exhibit fractional charge. New theoretical research from MIT physicists explains how it could work, suggesting that electron interactions in confined two-dimensional spaces lead to novel quantum states, [...]
Inside the Nano-Universe: New 3D X-Ray Imaging Transforms Material Science
A cutting-edge X-ray method reveals the 3D orientation of nanoscale material structures, offering fresh insights into their functionality. Researchers at the Swiss Light Source (SLS) have developed a groundbreaking technique called X-ray linear dichroic orientation tomography [...]
X-chromosome study reveals hidden genetic links to Alzheimer’s disease
Despite decades of research, the X-chromosome’s impact on Alzheimer’s was largely ignored until now. Explore how seven newly discovered genetic loci could revolutionize our understanding of the disease. Conventional investigations of the genetic contributors [...]
